Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Briacell Therapeutics Corp BCTX


Primary Symbol: T.BCT Alternate Symbol(s):  BCTXW

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.


TSX:BCT - Post by User

Comment by Iseneschalon Dec 10, 2020 12:13pm
169 Views
Post# 32077202

RE:RE:GLSI Move

RE:RE:GLSI Move
Pandora wrote:
Heynow123 wrote: What does the GLSI move mean for us BCT bag holders? Ignored on the news...


This is what a lot of BCT shareholders are looking for. I would certainly kick myself if it was to happen:

Yesterday's close $5.29
Today's open $12.15
Today's high $158
Today's close $57
Today after hours $79.50

Shares of Greenwich LifeSciences Inc. blasted 2,399.3% higher in very active and volatile afternoon trading Wednesday, after the Texas-based biopharmaceutical company displayed upbeat results of a Phase IIb trial for its breast cancer treatment. The stock, which has been halted no less than 20 times for volatility, was easily the biggest gainer trading on major U.S. exchanges, while trading volume of 15.9 million shares was many multiples of the full-day average of about 22,000 shares. The company said before the open that a poster presentation of five-year data for the GP2 clinical trial met all of its endpoints and showed zero recurrence of breast cancer in patients who had previously undergone surgery. The stock, which went public on Sept. 25, was now trading 2,159.7% above its $5.75 initial public offering price.


JUst to let u know..... those stats are very mis-leading....if u read carefully.....the Placebo Group also had a Survival Rate of 84.5%....so net net.....GLSI S.R is actually 15.5%........... Take a lokk at GLSI's website and compare it to BCT's....... GLSI is a "Godaddy" style.....our research is very professional......I personnally think GLSI is a bunch of "Smoke & Mirrors".... I am a shareholder of BCT...... adding when I can. Cheers!

<< Previous
Bullboard Posts
Next >>